Five Prime Therapeutics, Inc. Operating Lease, Liability, Noncurrent
Five Prime Therapeutics, Inc. had Operating Lease, Liability, Noncurrent of $42.31 million as of 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2021-03-22
- 2020-12-31: Operating Lease, Liability, Noncurrent $42.31M.
- 2020-09-30: Operating Lease, Liability, Noncurrent $42.10M.
- 2020-06-30: Operating Lease, Liability, Noncurrent $43.20M.
- 2020-03-31: Operating Lease, Liability, Noncurrent $44.41M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2020-12-31 | $42.31M 10-K · filed 2021-03-22 |
| 2020-09-30 | $42.10M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $43.20M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $44.41M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $45.53M 10-K · filed 2021-03-22 |
| 2019-09-30 | $46.57M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $47.60M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $48.60M 10-Q · filed 2019-05-09 |